[Federal Register Volume 83, Number 223 (Monday, November 19, 2018)]
[Notices]
[Pages 58267-58268]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25116]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory 
Board (DTAB) will convene via in person and web conference on December 
4, 2018, from 9:00 a.m. EST to 3:30 p.m. EST and December 5, 2018, from 
9:00 a.m. EST to 4:00 p.m.
    The Board will meet in open-session in-person on December 4, 2018, 
from 9:00 a.m. EST to 3:30 p.m. EST to discuss the proposed Mandatory 
Guidelines for Federal Workplace Drug Testing Programs (urine 
specimens) with updates from the Department of Transportation, Nuclear 
Regulatory Commission, and the Department of Defense. There will be 
additional presentations from the Division of Workplace Programs' staff 
on urine, oral fluid, hair Mandatory Guidelines and future direction, 
updates on electronic chain of custody and standard variables, and 
emerging issues surrounding marijuana legalization. The board will meet 
in closed-session in-person on

[[Page 58268]]

December 5, 2018, from 9:00 a.m. EST to 4:00 p.m. EST to discuss 
confidential issues surrounding the proposed Mandatory Guidelines for 
Federal Workplace Drug Testing Programs (urine specimens, oral fluid, 
hair), invalids, studies from Johns Hopkins Behavioral Pharmacology 
Research Unit, impact of cannabis laws on drug testing and future 
direction, potential recommendations to the Assistant Secretary for 
Mental Health and Substance Use regarding additional drugs that may be 
tested for in the future, and lastly, program financials. Therefore, 
the December 5, 2018, meeting is closed to the public, as determined by 
the Assistant Secretary for Mental Health and Substance Use, SAMHSA, in 
accordance with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, 
Section 10(d).
    Meeting registration information can be completed at http://snacregister.samhsa.gov/MeetingList.aspx. Web conference and call 
information will be sent after completing registration. Meeting 
information and a roster of DTAB members may be obtained by accessing 
the SAMHSA Advisory Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings or by contacting the Designated Federal 
Officer, CAPT Sean J. Belouin, USPHS.

    Committee Name: Substance Abuse and Mental Health Services 
Administration, Center for Substance Abuse Prevention, Drug Testing 
Advisory Board.
    Dates/Time/Type: December 4, 2018, from 9:00 a.m. to 3:30 p.m. 
EST: Open; December 5, 2018, from 9:00 a.m. to 4:00 p.m. EST: 
Closed.
    Place: Hilton Washington DC/Rockville Hotel & Executive Meeting 
Center, 1750 Rockville Pike, Rockville, MD 20852.
    Contact: CAPT Sean J. Belouin, USPHS, Senior Pharmacology and 
Regulatory Policy Advisor, Division of Workplace Programs, 5600 
Fishers Lane, Room 16N06D, Rockville, Maryland 20857, Telephone: 
(240) 276-2600, Email: [email protected].

Charles LoDico,
Chemist.
[FR Doc. 2018-25116 Filed 11-16-18; 8:45 am]
 BILLING CODE 4162-20-P